Fiducient Advisors LLC Takes Position in Colgate-Palmolive (NYSE:CL)

Fiducient Advisors LLC purchased a new position in shares of Colgate-Palmolive (NYSE:CL) during the second quarter, HoldingsChannel reports. The firm purchased 2,121 shares of the company’s stock, valued at approximately $206,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in shares of Colgate-Palmolive by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock valued at $6,368,378,000 after buying an additional 416,853 shares in the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Colgate-Palmolive by 27.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after purchasing an additional 8,933,912 shares in the last quarter. Norges Bank purchased a new stake in shares of Colgate-Palmolive in the fourth quarter worth approximately $731,843,000. GUARDCAP ASSET MANAGEMENT Ltd lifted its holdings in shares of Colgate-Palmolive by 4.1% in the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company’s stock valued at $629,220,000 after purchasing an additional 278,150 shares in the last quarter. Finally, Acadian Asset Management LLC boosted its position in shares of Colgate-Palmolive by 108.4% during the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock valued at $551,367,000 after buying an additional 2,955,442 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Insiders Place Their Bets

In other news, insider Panagiotis Tsourapas sold 14,794 shares of the stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the sale, the insider now directly owns 5,146 shares of the company’s stock, valued at $529,729.24. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the completion of the transaction, the insider now directly owns 5,146 shares in the company, valued at approximately $529,729.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Gregory Malcolm sold 10,533 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the transaction, the executive vice president now directly owns 10,377 shares in the company, valued at approximately $1,069,868.70. The disclosure for this sale can be found here. Insiders sold a total of 43,490 shares of company stock worth $4,486,063 in the last quarter. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Price Performance

CL opened at $107.86 on Friday. The firm has a 50-day moving average price of $101.07 and a 200-day moving average price of $94.52. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $109.30. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 16.90. The company has a market capitalization of $88.49 billion, a price-to-earnings ratio of 34.13, a PEG ratio of 3.73 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The business had revenue of $5.06 billion during the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. Colgate-Palmolive’s revenue was up 4.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.77 EPS. Equities analysts expect that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were issued a dividend of $0.50 per share. The ex-dividend date was Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a yield of 1.85%. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

Wall Street Analyst Weigh In

A number of research firms recently commented on CL. Evercore ISI raised their price objective on Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Stifel Nicolaus raised their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, July 22nd. Argus upped their price objective on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research report on Wednesday, May 15th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Colgate-Palmolive from $104.00 to $107.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. Finally, Morgan Stanley upped their target price on Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a report on Monday, July 29th. Eight analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $102.53.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.